Lactobacillus brevis T2102 suppresses the growth of colorectal cancer cells by activating SIRT1

• Main Authors: Gakuro Harada, Pawat Pattarawat, Kenji Ito, Takashi Matsumoto, Takanori Hasegawa, Yoshinori Katakura
• Format: Article
• Language: English
• Published: Elsevier 2016-05-01
• Series: Journal of Functional Foods
• Subjects: Lactic acid bacteria; SIRT1; Colorectal cancer; β-catenin; hTERT
• Online Access: http://www.sciencedirect.com/science/article/pii/S1756464616000190

SIRT1 is known to have critical functions in the maintenance of homeostasis and cell survival, and it confers anti-ageing effects on cells and tissues. To identify novel foods and food ingredients with potential anti-ageing functions, a novel system for screening substances that activate the SIRT1 promoter in human colorectal cancer cells was established. We screened several lactic acid bacteria (LAB) and identified Lactobacillus brevis T2102 as a SIRT1-activating strain of LAB. T2102 inactivated β-catenin through SIRT1-mediated deacetylation and consequently suppressed the growth of the human colorectal cancer cell line DLD-1. Furthermore, T2102-induced degradation of β-catenin repressed transcription of the human telomerase reverse transcriptase (hTERT) gene, one of the target genes of β-catenin, which led to the induction of cellular senescence and concomitant growth suppression of DLD-1. These results indicate that SIRT1-activating T2102 might be a promising candidate for developing novel functional foods with anti-cancer properties.